Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Medical Oncology
•
Supportive Care
•
Hospital Medicine
How would you manage cancer-associated hypoalbuminemia causing significant anasarca?
Does albumin infusions have a role?
Related Questions
Can defibrotide be given safely for VOD in patients with refractory thrombocytopenia to platelet transfusions?
How do you manage critically ill poor risk mixed germ cell tumor patients presenting de novo with extensive lung metastases and severe respiratory failure?
Would you favor oral bisphosphonates over intravenous formulations for patients with hormone sensitive prostate cancer and androgen deprivation therapy (ADT) related osteopenia?
How would you manage concurrent immunotherapy-related colitis and C. difficile infection?
How do you approach anti-seizure medication management when it was started by another team for a seizure-naive patient before/after craniotomy for a tumor?
Similar to the HFA-ICOS risk stratification tool for patients on chemotherapy, are there cardiac risk calculators available for use in patients starting immunotherapy?
How would you manage a patient with FIGO stage IIIB endometrial carcinoma who developed significant back pain with Carboplatin/Paclitaxel cycle 1, which worsened during cycle 2?
Excluding CLL, in which patients would you screen for hypogammaglobulinemia?
Does an allergy to the platinum metal, with moderate reaction to platinum inhaled particles, confer allergy to platinum-based chemotherapy?
What are your top takeaways in Hematologic Malignancies from ASH 2024?
